Any cancer is scary, but lung cancer is a particularly insidious disease – 70% of all lung cancers are diagnosed in advanced stages. Lung cancer is the most common and deadliest form of cancer with a five-year survival rate of less than 18%. An average of seven British Columbians die each day from lung cancer, making prevention and early detection the key to saving more lives.
Who should be screened for lung cancer?
A screening test can help those who have the highest risk for lung cancer:
People 55 and older who are or were heavy smokers
Smokers or those who quit within the last 15 years
Did you know?
- 1 in 2 British Columbians will be diagnosed with cancer in their lifetime – lung cancer is the most common and deadliest form
- Poor air quality and air pollution have been linked to lung cancer
- Screening tests help detect problems before symptoms arise increasing the chance of finding the problem early
- Early screening in BC is expected to diagnose approximately 150 lung cancer cases annually
- Lung cancer screening is done with a low-dose CT scan. A CT scan uses X-rays, or radiation, to make detailed pictures of your body
Learn more about Lung Cancer Screening.
Innovative lung cancer screening pilot program at VGH
Drawing on the expertise of respiratory medicine, thoracic surgery and radiology, the Lung Cancer Screening Pilot Program at Vancouver General Hospital pioneered a new model for lung cancer screening for British Columbians. It is the first large scale demonstration project of its kind in North America.
Launched in 2016, the program’s goal was to enroll 2,000 high risk individuals over three years with a two-year follow-up thereafter. The study was international in scope and examines the value of inclusion of air pollution exposures for risk assessment. It also applied advanced computer technology with the goal of improving efficiency and accuracy of reading large number of screening CT scans, as well as decreasing unnecessary imaging studies or biopsies.
Initial results from the donor-funded study was successful in laying down the groundwork for a first in Canada BC-wide lung cancer screening program.
Lung cancer patients at VGH will now receive additional support through a nurse navigator pilot program, funded by a $1M donation from Della and Stuart McLaughlin.
Jason and Emily Ko are committed to helping medical experts VGH detect lung cancer earlier.
Thanks to a $1.2-million-dollar gift from philanthropists Jason and Emily Ko, founders of Viva Pharmaceutical Inc., an innovative and potentially life saving lung cancer screening pilot program was made possible at VGH
We are grateful to Jason and Emily Ko whose impact in funding this important screening program is transforming health care globally.
“Lung cancer is a cause that is very close to my heart. Many of my friends, who were non-smokers, have been impacted by lung cancer. I wanted to give a gift that will impact people all over the world,” says Jason Ko.
Learn more about Emily and Jason’s donation.
